Lauren R Pacek1, Maggie M Sweitzer2, F Joseph McClernon2. 1. Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States. Electronic address: lauren.pacek@duke.edu. 2. Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States.
Abstract
INTRODUCTION: Smoking is more prevalent among persons living with HIV (PLWH) than the general population. Little is known about the prevalence of non-cigarette tobacco and poly-tobacco use (PTU; using multiple tobacco products) among this population, which, in the general population is associated with poor health and cessation outcomes. We aimed to characterize the prevalence of cigarette and non-cigarette tobacco use, PTU, and correlates of tobacco use status among a nationally-representative sample of PLWH. METHODS: Data came from 472 HIV-positive adults from the 2005-2013 National Survey on Drug Use and Health (NSDUH). RESULTS: The prevalence of PTU overall was 8.7% (95% CI=5.6-13.2), and 16.6% (95% CI=10.2-25.7) among past-year tobacco users. In multinomial logistic regression analyses, participants with a high school education or greater (aRRR=2.03, 95% CI=1.03-4.00) were more likely to be non-tobacco users than single product users. Past year drug users (aRRR=0.35, 95% CI=0.19-0.66) and past month binge drinkers (aRRR=0.24, 95% CI=0.12-0.50) were less likely to be non-tobacco users than single product users. Compared to 18-25 year olds, individuals age 26-34 (aRRR=0.13, 95% CI=0.03-0.65) and 35+ (aRRR=0.24, 95% CI=0.09-0.63), and with lifetime anxiety disorder(s) (aRRR=0.18, 95% CI=0.06-0.57) were less likely to be PTUs as compared to single product users. Individuals who reported liking to test themselves by doing risky things were more likely to be PTUs than single product users (aRRR=2.95, 95% CI=1.27-6.84). CONCLUSIONS: PTU was slightly higher than in the general population, and should be taken into account when developing cessation interventions tailored to tobacco users living with HIV.
INTRODUCTION: Smoking is more prevalent among persons living with HIV (PLWH) than the general population. Little is known about the prevalence of non-cigarette tobacco and poly-tobacco use (PTU; using multiple tobacco products) among this population, which, in the general population is associated with poor health and cessation outcomes. We aimed to characterize the prevalence of cigarette and non-cigarette tobacco use, PTU, and correlates of tobacco use status among a nationally-representative sample of PLWH. METHODS: Data came from 472 HIV-positive adults from the 2005-2013 National Survey on Drug Use and Health (NSDUH). RESULTS: The prevalence of PTU overall was 8.7% (95% CI=5.6-13.2), and 16.6% (95% CI=10.2-25.7) among past-year tobacco users. In multinomial logistic regression analyses, participants with a high school education or greater (aRRR=2.03, 95% CI=1.03-4.00) were more likely to be non-tobacco users than single product users. Past year drug users (aRRR=0.35, 95% CI=0.19-0.66) and past month binge drinkers (aRRR=0.24, 95% CI=0.12-0.50) were less likely to be non-tobacco users than single product users. Compared to 18-25 year olds, individuals age 26-34 (aRRR=0.13, 95% CI=0.03-0.65) and 35+ (aRRR=0.24, 95% CI=0.09-0.63), and with lifetime anxiety disorder(s) (aRRR=0.18, 95% CI=0.06-0.57) were less likely to be PTUs as compared to single product users. Individuals who reported liking to test themselves by doing risky things were more likely to be PTUs than single product users (aRRR=2.95, 95% CI=1.27-6.84). CONCLUSIONS:PTU was slightly higher than in the general population, and should be taken into account when developing cessation interventions tailored to tobacco users living with HIV.
Authors: Israel T Agaku; Filippos T Filippidis; Constantine I Vardavas; Oluwakemi O Odukoya; Ayodeji J Awopegba; Olalekan A Ayo-Yusuf; Gregory N Connolly Journal: Drug Alcohol Depend Date: 2014-03-15 Impact factor: 4.492
Authors: Marie Helleberg; Jan Gerstoft; Shoaib Afzal; Gitte Kronborg; Carsten S Larsen; Court Pedersen; Stig E Bojesen; Børge G Nordestgaard; Niels Obel Journal: AIDS Date: 2014-06-19 Impact factor: 4.177
Authors: Jennifer Cullen; Paul Mowery; Cristine Delnevo; Jane A Allen; Natasha Sokol; M Justin Byron; Amber Thornton-Bullock Journal: Am J Public Health Date: 2011-08-18 Impact factor: 9.308
Authors: Matthew S Freiberg; Kathleen A McGinnis; Kevin Kraemer; Jeffrey H Samet; Joseph Conigliaro; R Curtis Ellison; Kendall Bryant; Lewis H Kuller; Amy C Justice Journal: J Acquir Immune Defic Syndr Date: 2010-02 Impact factor: 3.731
Authors: Jennifer O Lam; Tory Levine-Hall; Nicole Hood; Stacey E Alexeeff; Michael A Horberg; Kelly C Young-Wolff; Stacy A Sterling; Andrew Williams; Constance Weisner; Derek D Satre; Michael J Silverberg Journal: Drug Alcohol Depend Date: 2020-06-18 Impact factor: 4.852